Sign in
Stories
AlloVir Faces Class Action Allegations
Share
Assertio Holdings Faces Securities Law I...
Biotech Legal Updates: Lawsuits and Dism...
Class Action Lawsuits Filed Against Apel...
AlloVir Class Action Lawsuit Filed
AlloVir Faces Class Action Lawsuit
AlloVir Faces Lawsuit Over Statements
Overview
API
Investors are reminded of the lead plaintiff deadline for a class action against AlloVir, Inc. for allegedly misleading statements about its posoleucel Phase 3 Studies, leading to a stock drop after study discontinuation.
Ask a question
Could this legal issue affect other companies in the clinical-stage cell therapy industry?
How might the outcome of this lawsuit impact AlloVir's future operations and reputation?
What measures could AlloVir take to address investor concerns and regain trust?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage